when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

by stage

Marketed
Phase 3
Phase 2
Phase 1
Preclinical

browse

Most catalysts
Recently active
All drugs →
Companies
Patent cliff

what

Trial readouts
PDUFA dates
Approvals
Earnings

when

Upcoming
Month grid
Recently passed

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News
Drugs
Calendar
Companies

Hubs

Topics
Patent cliff
Publications
Readouts

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

Oncology · news · pharmadog

← back to Oncology

News · Oncology

1,499 stories

Jul 17, 26Updated: BlossomHill and Latigo join flourishing IPO queue with cancer, pain drugsendpoints

Jul 17, 26GSK shelves cough drug acquired in $2B dealbiopharma dive

Jul 17, 26BlossomHill eyes IPO as fertilizer to grow taller in crowded cancer fieldsfiercebiotech

Jul 17, 26Abbott Q2 led by strong device, diagnostic sales as it boosts profit forecastfiercebiotech

Jul 16, 26Predicting biotech clinical trials and a new Alzheimer’s drug controversystat

Jul 16, 26Pete Hegseth’s announcement of annual testosterone screenings for service members divides medical expertsstat

Jul 16, 26Lilly to buy AtaiBeckley for $2.8B, further validating psychedelicsbiopharma dive

Jul 16, 26‘Substantially better than before’: Why India has golden opportunity to build on innovative R&D winsfiercebiotech

Jul 16, 26Chutes & Ladders—Cue lines up new CMO and research headfiercebiotech

Jul 16, 26Kelun pads efficacy profile of Merck-partnered ADC; Europe will have to wait for Boehringer's Hernexeosendpoints

Jul 16, 26Merck wins first approval of a PCSK9 cholesterol pillbiopharma dive

Jul 16, 26STAT+: FDA approves Merck’s oral PCSK9 drug, a firststat

Jul 16, 26Braveheart, Attovia, Vogenx keep IPOs ballooning with plans to compete in cardiometabolic, immunobiospace

Jul 16, 26STAT+: Kalshi comes for biopharma, with prediction markets for clinical trials and FDA approvalsstat

Jul 16, 26STAT+: Eli Lilly to acquire psychedelics-focused biotech AtaiBeckleystat

Jul 16, 26STAT+: Amylyx nears pivotal endocrine drug study readoutstat

Jul 16, 26Opinion: The growing fang-to-pharmacy pipelinestat

Jul 16, 26STAT+: CMS signals intent to revamp how it pays for clinical software and AIstat

Jul 16, 26CDER plans new guidance on AI, electronic safety report submissions, and moreraps

Jul 16, 26Drug repurposing: Stakeholders say FDA should act within its authority, avoid disincentivesraps

Jul 15, 26Celcuity gains FDA approval for closely watched breast cancer drugbiopharma dive

Jul 15, 26STAT+: In a major policy shift, Medicare proposes to ban vendors from providing remote monitoring servicesstat

Jul 15, 26Merck ADC, in China study, shows potential to replace chemo in lung cancerbiopharma dive

Jul 15, 26Radiopharma maker AdvanCell hauls in $315M for Pluvicto challengerendpoints

Jul 15, 26STAT+: Celcuity’s breast cancer drug approved, its firststat

Jul 15, 26Deaths from coronary artery disease have fallen, but more progress is within reachstat

Jul 15, 26Kelun’s Merck-partnered ADC notches late-stage NSCLC win alongside Keytrudabiospace

Jul 15, 26J&J dips despite upbeat outlook; AstraZeneca, Spero cut China dealsbiopharma dive

Jul 15, 26STAT+: Pharmalittle: We’re reading about a Biogen Alzheimer’s drug, skyrocketing 340B drug sales, and morestat

Jul 14, 26STAT+: FTC settles lawsuit with CVS Caremark over charges it manipulated insulin prices, impeded accessstat

← prevpage 31 of 50next →